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Key Words Abstract 
^-adrenoceptors Compared to 7 healthy women, an altered |32-adrenoceptor/cyclic adenosine 
cAMP monophosphate (cAMP) system has been observed in a combined study on 
Peripheral blood leukocytes both expression and function of (^-adrenoceptors on peripheral blood leuko-
Atopy cytes (PBL) of 7 atopic women suffering from acute seasonal rhinoconjunctiv-
Seasonal allergic rhinoconjunctivitis itis. A reduced affinity of the (^-adrenergic radioligand 12SIcyanopindolol to its 
binding site (equilibrium dissociation constant K d 6.4± 1.0 vs. 3.4±0.6 pmol/1 in 
controls; p<0.05), a reduced sensitivity of the intracellular cAMP formation to 
isoprenaline (concentration necessary to achieve half-maximal effectiveness 
ECso 1,088.6±669.0 vs. 71.0±51.0 nmol/1 in controls; p<0.01), and a reduced 
intracellular cAMP increase in response to isoprenaline ( E m a x as a percentage 
of the basal cAMP content E ( , 117±3 vs. 145±8% E { ) in controls; p<0.01) point 
to a subsensitivity of (^-adrenoceptors. A reduced E ( , (4.9±0.8 vs. 8.4±1.3 
pmol/106 cells in controls; p<0.05) suggests an increased activity of the cAMP-
degrading enzyme phosphodiesterase. A reduced sympathetic tone in atopy 
was further confirmed by lower cAMP plasma concentrations (25.7±1.2 vs. 
31.3±1.6 nmol/1 in controls; p<0.05). The results indicate that more than just 
one mechanism are involved in the impairment of the PBL (^-adrenoceptor/ 
cAMP system in atopy. 
Introduction 
Activation of ^ -adrenoceptors may inhibit the release 
of mediators like histamine [1]; (3-sympathomimetic drugs 
are most effective in relieving acute shortness of breath in 
bronchial asthma [2]. In agreement with these observa-
tions, Szentivanyi [3] suggested that a subsensitivity of 
(> adrenergic receptors due to a disturbance of their ex-
pression and/or function may be related to the pathophys-
iology of atopic bronchial asthma. Further reports have 
indicated a subsensitivity of (3-adrenoceptors also in other 
atopic diseases [4, 5]. 
Usually either the expression of (^-adrenoceptors or 
their function has been investigated in studies on the (3-
adrenergic system in atopic disease. However, to fully de-
scribe receptors pharmacologically, both aspects have to 
be evaluated. We recently reported a decreased affinity of 
PBL (^-adrenoceptors in atopic bronchial asthma that was 
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correlated with the stimulation of the intracellular forma-
tion of cyclic adenosine monophosphate (cAMP) by iso-
prenaline [6]. We have now investigated atopic patients 
with seasonal allergic rhinoconjunctivitis during the acute 
phase of their disease. 
Materials and Methods 
Patients and Controls 
20 ml of venous blood was drawn from the antecubital vein of 
7 healthy women (21-51 years of age) and 7 atopic women suffering 
from seasonal allergic rhinoconjunctivitis (22^ 42 years of age). All 
samples were taken between 0830 and 09.30 h in the morning to avoid 
that the results were influenced by circadian variations [7]. The study 
was performed in April/May. All subjects had a negative history and 
showed no signs of pulmonary, cardiac, renal, and hepatic disease, 
nor of any other disease by clinical inspection. No drugs were taken. 
The patients had a history of seasonal rhinoconjunctivitis (April-
August) for 4-20 years. They had no personal history of perennial 
rhinoconjunctivitis and no personal or family history of any other 
atopic disease (asthma, atopic eczema). Allergy to the relevant al-
lergens (birch or grass pollen) had been adequately demonstrated 
(prick test, radioallergosorbent test). The investigations started in the 
pollen season after symptoms had been present for at least 3 days. 
Antiallergic drugs had not yet been taken. 
The healthy subjects had no personal or family history of allergic 
rhinoconjunctivitis and/or any other atopic disease (asthma, atopic 
eczema) and showed no skin prick reactions to house dust mite, cat 
epithelia, nor to grass pollen. 
Methods 
Dextran (Macrodex® 6%; Pfrimmer, Erlangen, FRG) was added 
to the blood directly after venipuncture, and cells were separated by 
gravity sedimentation under light protection (room temperature, 
90min). The leukocyte-rich supernatant was separated from the 
precipitate of erythrocytes and centrifugated at 1,200 rpm for 10 min 
at 4°C. The resulting cell pellet was washed thwice in T C M buf-
fer (pH7.4) containing 3.0 g/1 tris(hydroxymethyl)aminomethane, 
0.3 g/1 KC1, 7.0 g/1 Nacl, 0.147 g/1 CaCl x 2H 2 0, and 0.2 g/1 MgCl 2 x 
6H 2 0. The cell concentration was finally adjusted to 5 x 106 cells/ml. 
The expression of (^-adrenoceptors was studied in radioreceptor 
assays with twelve concentrations of (-)-i25Icyanopindolol ( 1 2 5I-CYP; 
Amersham Buchler, Braunschweig, FRG) in the range of 1.0-150.0 
pmol/1 as described elsewhere [8]. The number of high-affinity bind-
ing sites (Bm a x) and their equilibrium dissociation constant (Kd) were 
determined by nonlinear regression analysis. 
The function of (^-adrenoceptors was tested by incubating leuko-
cytes with five concentrations of isoprenaline (10~8 to 10"4 mol/1) for 
10 min at 37 °C. The basal intracellular cAMP content (E 0), the c AMP 
content maximally achievable by incubation with isoprenaline (E m a x ) , 
and the effective isoprenaline concentration necessary to achieve 
half-maximal stimulation (EC 5 0 ) were determined by nonlinear re-
gression analysis. Intracellular cAMP and plasma cAMP were deter-
mined by radioimmunoassay (Amersham Buchler). 
Mean values are given with their standard errors. To test for 
differences between patients and healthy controls a Student t test was 
used. The significance level was a = 0.05 
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Fig, 1. Expression of (^-adrenoceptors on peripheral blood leuko-
cytes of 7 atopic women suffering from seasonal allergic rhinocon-
junctivitis compared to 7 healthy women. (^-Adrenoceptor density 
(top panel) and the equilibrium dissociation constant (a parameter 
representing inversely the affinity of adrenergic ligands to (^ -adreno-
ceptors, lower panel) were determined in radioreceptor assays with 
the adrenergic radioligand , 2 5I-CYP. Mean values±SE are shown. 
Results 
No significant differences were observed in the B m a x 
values of patients (1,607±94 l 2 5I-CYP-binding sites/cell) 
and controls (1,863±248 1 2 5I-CYP-binding sites/cell; fig. I 
top panel). K d , however, was increased in the atopic pa-
tients (6.4±1.0 vs. 3.4±0.6 pmol/1 in controls; p<0.05), 
indicating a decreased affinity of the adrenergic radioli-
gand for its binding site (fig. 1, bottom panel). 
Eo of leukocytes obtained from the atopic patients 
(4.9±0.8 pmol/106 cells) was significantly lower than in the 
healthy subjects (8.4±1.3 pmol/106 cells; p<0.05; fig. 2, 
top panel). E m a x (expressed as a percentage of Eo) w a s 
significantly decreased in the atopic patients (117±3 vs. 
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Fig. 2. Function of (^-adrenoceptors on peripheral blood leuko-
cytes of 7 atopic women suffering from seasonal allergic rhinocon-
junctivitis compared to 7 healthy women. Basal cAMP content (top 
panel), its increase maximally achievable by incubating the cells with 
isoprenaline (middle panel), and the isoprenaline concentration nec-
essary to achieve the half-maximal effect (a parameter representing 
inversely the sensitivity of (^-adrenoceptors to adrenergic ligands, 
lower panel) were determined from dose-response curves for isopre-
naline. Data represent mean values±SE. 
Fig. 3. cAMP plasma concentration, a general marker for the 
sympathetic tone, of 7 atopic women suffering from seasonal allergic 
rhinoconjunctivitis compared to 7 healthy women. Mean values±SE 
are shown. 
145±8% Eo in controls; p<0.01; fig. 2, middle panel). 
E C 5 0 was higher in the atopic patients than in the healthy 
subjects (1,088.6±669.0 vs. 71.0±5L0 nmol/1; p<0.01; 
fig. 2, bottom panel), indicating a reduced sensitivity of 
(^-adrenoceptors to [3-adrenergic stimuli. 
The c A M P plasma concentrations were decreased in 
the atopic patients, too (25.7±1.2 nmol/1 in patients vs. 
31.3±1.6 nmol/1 in controls; p<0.05; fig. 3). 
Discussion 
The results point to an altered expression and function 
of ^-adrenoceptors on P B L in patients with seasonal rhi-
noconjunctivitis. Compared to controls, the results dem-
onstrate three features of the P B L |32-adrenoceptor/ 
cAMP system that are compatible with 'subsensitivity of 
^-adrenoceptors P B L in atopic disease: (1) a reduced af-
finity of the (3-adrenergic radioligand to its binding site 
(K d ); (2) a reduced sensitivity of the intracellular c A M P 
formation to (3-adrenergic stimuli (EC 5 0 ) , and (3) a re-
duced intracellular cAMP increase in response to isopre-
naline ( E m a x expressed as a percentage of E 0 ) . Corre-
spondingly, cAMP plasma concentrations, a general 
marker for the sympathetic tone, were found reduced as 
well. 
However, subsensitivity of (^-adrenoceptors does not 
sufficiently explain the reduced basal c A M P content of 
the cells. The basal c A M P content reflects the steady state 
between intracellular formation and degradation of 
cAMP. Besides decreased formation of c A M P , an in-
creased activity of the cAMP-degrading enzyme phospho-
diesterase would, therefore, result in a reduced basal 
c A M P content, too. Such an increased phosphodiesterase 
activity had been suggested by Grewe et al. [9]. More than 
just one mechanism seems to be involved in the im-
pairment of the P B L (32-adrenoceptor/cAMP system in 
atopy. 
Regardless whether the impairment of the PBL p,-
adrenoceptor/cAMP system in atopic seasonal rhinocon-
junctivitis is primary or secondary due to disease, it may 
be pathophysiological^ relevant. Further work is under 
way in order to elucidate possible changes in the reported 
variables during and out of the symptomatic season. 
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